PMID: 44908Jan 1, 1979

Treatment of acute bacterial bronchitis and pneumonia with cefaclor

Postgraduate Medical Journal
W J MogabgabJ G Jemsek

Abstract

Sixty patients with pneumonia and/or bronchitis were treated with cefaclor, a new orally administered cephalosporin. Of those 60, 27 adults were treated with 500 mg every 8 hours, 26 adults with 250 mg every 6 hours, and 7 children with 50 mg/kg/day. In the adults, pneumonia was caused most frequently by Streptococcus pneumoniae and Haemophilus influenzae. The 7 children had pneumococcal pneumonia. All but 2 adults, both elderly patients with chronic obstructive pulmonary disease, were successfully treated. One instance of drug hypersensitivity occurred. All 7 children responded rapidly, with no side effects, to cefaclor therapy.

Related Concepts

Haemophilus influenzae
Meningitis, Haemophilus
Sputum, Induced
Acute Disease
Cephalosporins
Bronchitis
Lilly 99638
Experimental Lung Inflammation
Acute Bronchitis
Cephalexin, Monosodium Salt, (6R-(6alpha,7beta))-Isomer

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.